Astrazeneca Stock AnalysisAstrazeneca Stock Analysis
Prices moving inside a channel - trendless condition - Horizontal movement.
Based on Technical Analysis, the idea is to go long as the prices are close to the resistance level of 83 pound (bottom flat line of the channel) and they seem ready to jump up to 88.0 Pound.
Astrazeneca
MRNA- Leader in the vaccine race. Ladder buy to avoid the riskModerna is the first company to start the phase 3 trial in July and could have the supply ready earliest by Oct and accelerated approval earliest by December, according to Nami Sumida/BioPharma Dive and morningstar.
Other competitors are scheduled to have accelerated approval the earliest around early 2021.
Science Backed by Data[AstraZeneca Series]: Target 3949Good Evening Friends,
AstraZeneca is in very long term uptrend(24 months). It has breaken out today after consolidating for past few 3-4 weeks. Breakout has been on very health volumes almost 4.5 times average volumes(331K vs 78K average volume)
RSI is in uptrend and looks promising.
Buy Closer to 3576 levels
Support Levels
2939 (below this trend may get invalidated on short term)
3302
3451
3520
3565
Target
1st Target 3949 ,
2nd target 4188
Pls support with likes on the idea.
Schrödinger $SDGRRecent IPO Schrödinger extends its existing collaboration with AstraZeneca, $AZN, aimed at enhancing the former's Free Energy Perturbation technology for the optimization of key properties of biologics, particularly binding affinity. As technically, it is rising and needs to break the trendlines and hold above $45.
A little jump before big dump ?!Still bullish on AZN.L but ascending broadening wedge :
- Need to break 7 580$ resistance
- RSI divergence
- MM20 > MM50
Statiscally in 80% of cases, the exit of this pattern is bearish.
So, I will open a short position around 7 400 $. (TPs on chart)
Always 2 gap to fill :
- Around 6 930 $
- Around 6 550 $
Happy trading
AstraZeneca - Breaking from a wedgeBuy AstraZeneca (AZN.L)
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience.
Market Cap: £90.48Billion
AstraZeneca is breaking higher from a corrective wedge pattern on the daily chart. The long-term uptrend remains bullish and a move towards new highs is expected.
Stop: 6565p
Target 1: 7465p
Target 2: 7580p
Target 3: 8000p
Interested in UK Stocks?
Join our free Telegram channel for up to date analysis on the best main market opportunities in the UK right now - t.me
Astrazeneca resistanceIdea: Testing a strategy using the relationship of related time frames for measuring retracement high. I am expecting the retrace to have reached its maximum price limit and price to return to the short trend at 35.13.
DISCLAIMER:
This is where I practice ideas and work on my trading techniques. This is not investment advice. Please note I am only providing my own trading information for insight to my trading techniques, you should do your own due diligence and not take this information as a trade signal. Trade at your own risk.